N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

Sponsor: Washington University School of Medicine • ClinicalTrials.gov ID: NCT07853807

Registry updated: 2026-10-02
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

In Study 1, investigators will test the ability of each of the seven paradigms to differentiate between schizophrenia (SZ)/schizoaffective disorder (SZA) and matched healthy control subjects (HC) and to predict individual differences in clinical measures of hallucinations and delusions (as well as measures of function). Investigators will also directly compare the tasks in terms of predictive ability and psychometric properties and determine whether the tasks share variance or explain unique variance. This will include determining whether hallucinations and delusions are best explained by separate underlying processes or by a single process. Investigators will also test whether the model-based parameters from these studies are more precise and sensitive than standard behavioral methods for assessing deficits across psychotic disorders and for predicting hallucinations and delusions (Aim 1). Investigators will also validate key model-based parameters against well-characterized neurophysiological measures using electroencephalogram (EEG) (Aim 4). The data from Study 1 will also be used to optimize (e.g., length, floor, and ceiling effects) tasks for Study 2. To generate a sample with sufficient variation in hallucinations and delusions, investigators will recruit the following groups that balance feasibility with clinical relevance: A) healthy controls (HC) \[HC, N=125\]; B) schizophrenia and schizoaffective disorder \[SZ/SZA, N=200\]). For Study 1, investigators will ensure that 40 patients are unmedicated. Investigators anticipate a \~20% screen fail/drop-out rate based on our prior Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium (CNTRACS) studies. Thus, investigators will run an additional 40 SZ/SZA and 15 HC. All sites have experience recruiting patients in each of these groups as indicated by our past successful studies, and the fact that investigators have been able to recruit patients with significant hallucinations and delusions in all groups. Investigators will also validate key model-based parameters against well-characterized neurophysiological measures using electroencephalogram (EEG) (Aim 4). The data from Study 1 will also be used to optimize (e.g., length, floor, and ceiling effects) tasks for Study 2. To generate a sample with sufficient variation in hallucinations and delusions, investigators will recruit the following groups that balance feasibility with clinical relevance: A) healthy controls (HC) \[HC, N=125\]; B) schizophrenia and schizoaffective disorder \[SZ/SZA, N=200\]). For Study 1, investigators will ensure that 40 patients are unmedicated. Investigators anticipate a \~20% screen fail/drop-out rate based on our prior Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium (CNTRACS) studies. Thus, investigators will run an additional 40 SZ/SZA and 15 HC. All sites have experience recruiting patients in each of these groups as indicated by our past successful studies, and the fact that investigators have been able to recruit patients with significant hallucinations and delusions in all groups.

Interventions

  • Motion Perception Task (Behavioral)
    Assesses updating of beliefs from new sensory inputs with prior knowledge via perceiving direction changes in random dot motion stimuli
  • Sine Wave Speech Task (Behavioral)
    Measures the degree to which overweighting of prior beliefs impacts processing of sensory inputs (detection of speech).
  • Volatility Task (Behavioral)
    Measures the updating of priors about the location of a bag drop from a helicopter when the location changes (prediction errors).
  • Choice Probabilistic Reversal Task (Behavioral)
    Assesses prior belief updating when feedback about obtaining positive outcomes changes (prediction errors).
  • Kamin Blocking Task (Behavioral)
    Examines the role of mismatches between learned priors and new information (prediction errors) in belief formation about event causes.
  • Minnesota Trust Game (Behavioral)
    Assesses the degree to which people distinguish between their priors about others' motivations, such as selfishness and spite, and impersonal chance in one-shot trust game and dictator games.
  • Dynamic Trust Game (Behavioral)
    Assesses degree to which people learn and update priors about trusting partners from dynamic social feedback (prediction error) in a social exchange game.

Eligibility criteria

Inclusion Criteria: General Inclusion 1. age 18 to 59 2. no substance disorder in past six months (confirmed with urine drug screens and breathalyzers); 3. no clinically significant head injury or neurological disease. 4. Wechsler Test of Adult Reading (WTAR) score =16+. Group Specific Criteria: Schizophrenia/Schizoaffective Disorder (SZ): 1. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) diagnosis of schizophrenia or schizoaffective; 2. no medication changes in prior month or anticipated in the next month or not taking medications 3. outpatient or partial hospital if unmedicated Healthy Controls (HC): 1. no Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) Psychosis or Bipolar Disorder; 2. no family history of psychosis or bipolar Exclusion Criteria: Healthy Controls (HC): 1. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) Psychosis or Bipolar Disorder diagnosis 2. Family history of psychosis or bipolar Schizophrenia/Schizoaffective Disorder (SZ/SZA): additional exclusion criteria for the unmedicated individuals are: 1. not in acute exacerbation requiring immediate hospitalization or treatment 2. self-reported medication non-compliance for at least the four previous weeks 3)never having started medications

Conditions

SCHIZOPHRENIA 1 (Disorder) Schizoaffective Disorder Healthy Adult Participants

Locations

  • University of California, Irvine — Irvine, California, United States
  • The University of Chicago — Chicago, Illinois, United States
  • University of Maryland, Baltimore — Baltimore, Maryland, United States
  • University of Minnesota — Minneapolis, Minnesota, United States
  • Washington University — St Louis, Missouri, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record